Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

Q: What does CUSIP 03168L105 represent in this 13F holders report?

CUSIP 03168L105 is the security identifier for AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 used to aggregate holder disclosures.

Q: How many institutions held AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in Q2 2022?

140 institutional investors reported AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 03168L105

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Class A Common Stock, par value $0.01
Shares outstanding: 313,041,907
Total 13F shares: 99,362,374
Share change: -239,902
Total reported value: $315,991,849
Put/Call ratio: 73%
Price per share: $3.18
Number of holders: 140
Value change: -$2,095,558
Number of buys: 58
Number of sells: 68

Quarterly Holders Quick Answers

What is CUSIP 03168L105?
CUSIP 03168L105 identifies AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 03168L105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Fosun International Ltd	13F	Company	6.9%	21,521,301	$89,744,000	—	31 Mar 2022	13F
TPG GP A, LLC	13F	Company	5.2%	16,213,367	$67,610,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	4.1%	12,830,372	$53,504,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	2.3%	7,082,702	$29,535,000	—	31 Mar 2022	13F
Eversept Partners, LP	13F	Company	1.8%	5,491,497	$22,899,542	—	31 Mar 2022	13F
Neuberger Berman Group LLC	13F	Company	1%	3,198,368	$13,344,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.96%	2,998,880	$12,505,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.78%	2,446,545	$10,202,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.66%	2,078,281	$8,417,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.55%	1,712,671	$7,141,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.52%	1,639,322	$6,836,000	—	31 Mar 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.51%	1,587,956	$6,622,000	—	31 Mar 2022	13F
LSV ASSET MANAGEMENT	13F	Company	0.5%	1,552,200	$6,473,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.47%	1,465,120	$6,110,000	—	31 Mar 2022	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.39%	1,210,351	$4,982,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.38%	1,180,646	$4,924,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.33%	1,025,795	$4,277,000	—	31 Mar 2022	13F
JUPITER ASSET MANAGEMENT LTD	13F	Company	0.32%	990,854	$4,122,000	—	31 Mar 2022	13F
Hillsdale Investment Management Inc.	13F	Company	0.28%	861,716	$3,593,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.25%	784,082	$3,270,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.18%	566,337	$2,361,000	—	31 Mar 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.17%	518,245	$2,158,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.14%	439,257	$1,831,702	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.14%	422,653	$1,762,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.12%	363,385	$1,515,000	—	31 Mar 2022	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.12%	362,866	$1,513,000	—	31 Mar 2022	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.11%	349,320	$1,457,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.1%	325,249	$1,356,000	—	31 Mar 2022	13F
Joseph Todisco	3/4/5	Executive Vice President	— class O/S missing	327,194	$1,350,231	—	07 May 2022	3/4/5
DEUTSCHE BANK AG\	13F	Company	0.1%	299,129	$1,248,000	—	31 Mar 2022	13F
ALGERT GLOBAL LLC	13F	Company	0.09%	292,059	$1,218,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	262,143	$1,093,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.08%	253,999	$1,059,000	—	31 Mar 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.08%	236,998	$988,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.08%	236,802	$988,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.07%	231,749	$966,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.07%	229,600	$957,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.07%	223,514	$932,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	0.07%	209,933	$875,000	—	31 Mar 2022	13F
Brandywine Global Investment Management, LLC	13F	Company	0.07%	208,467	$869,000	—	31 Mar 2022	13F
HUSSMAN STRATEGIC ADVISORS, INC.	13F	Company	0.06%	180,000	$751,000	—	31 Mar 2022	13F
STRS OHIO	13F	Company	0.06%	178,900	$746,000	—	31 Mar 2022	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.06%	175,731	$733,000	—	31 Mar 2022	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.05%	167,973	$700,000	—	31 Mar 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.05%	165,694	$691,000	—	31 Mar 2022	13F
VIRGINIA RETIREMENT SYSTEMS ET Al	13F	Company	0.05%	150,600	$628,000	—	31 Mar 2022	13F
GLOBEFLEX CAPITAL L P	13F	Company	0.05%	148,707	$620,000	—	31 Mar 2022	13F
ClariVest Asset Management LLC	13F	Company	0.05%	147,518	$616,000	—	31 Mar 2022	13F
Grantham, Mayo, Van Otterloo & Co. LLC	13F	Company	0.05%	146,500	$611,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.05%	144,582	$603,000	—	31 Mar 2022	13F

Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2022

As of 30 Jun 2022, Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by 140 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 99,362,374 shares. The largest 10 holders included Fosun International Ltd, TPG GP A, LLC, VANGUARD GROUP INC, BlackRock Inc., Eversept Partners, LP, Point72 Asset Management, L.P., Neuberger Berman Group LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 140 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

154

Q2 2022 holders

140

Holder diff

-14

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.